PT967207E - Novos derivados de nitrona processo para a sua preparacao e as composicoes farmaceuticas que os contem - Google Patents
Novos derivados de nitrona processo para a sua preparacao e as composicoes farmaceuticas que os contemInfo
- Publication number
- PT967207E PT967207E PT99401565T PT99401565T PT967207E PT 967207 E PT967207 E PT 967207E PT 99401565 T PT99401565 T PT 99401565T PT 99401565 T PT99401565 T PT 99401565T PT 967207 E PT967207 E PT 967207E
- Authority
- PT
- Portugal
- Prior art keywords
- new
- preparation
- contain
- pharmaceutical compositions
- derivatives process
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9808116A FR2780404B1 (fr) | 1998-06-26 | 1998-06-26 | Nouveaux derives de nitrone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
PT967207E true PT967207E (pt) | 2002-12-31 |
Family
ID=9527896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT99401565T PT967207E (pt) | 1998-06-26 | 1999-06-24 | Novos derivados de nitrona processo para a sua preparacao e as composicoes farmaceuticas que os contem |
Country Status (17)
Country | Link |
---|---|
US (1) | US6034250A (pt) |
EP (1) | EP0967207B1 (pt) |
JP (1) | JP2000026428A (pt) |
CN (1) | CN1153766C (pt) |
AT (1) | ATE223904T1 (pt) |
AU (1) | AU747203B2 (pt) |
BR (1) | BR9903282A (pt) |
CA (1) | CA2274621C (pt) |
DE (1) | DE69902851T2 (pt) |
DK (1) | DK0967207T3 (pt) |
ES (1) | ES2183492T3 (pt) |
FR (1) | FR2780404B1 (pt) |
HU (1) | HUP9902199A1 (pt) |
NO (1) | NO312722B1 (pt) |
NZ (1) | NZ336460A (pt) |
PT (1) | PT967207E (pt) |
ZA (1) | ZA994201B (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6096899A (en) * | 1998-04-14 | 2000-08-01 | The Regents Of The University Of Michigan | Cylic imidazole compounds having relatively low hydrogen content and relatively high nitrogen content and polymers formed therefrom |
KR100986225B1 (ko) * | 2001-02-16 | 2010-10-07 | 아스비오파마 가부시키가이샤 | Aop-1 유전자 또는 aop-1의 발현 감소를수반하는 질환의 치료 방법 및 상기 질환의 치료약 |
WO2003010154A1 (en) * | 2001-07-26 | 2003-02-06 | Samsung Electronics Co. Ltd. | Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses |
EP1482931B1 (en) * | 2002-03-05 | 2011-10-19 | TransTech Pharma, Inc. | Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
AU2003230770A1 (en) * | 2002-03-28 | 2003-10-13 | Oxis International, Inc. | Neuroprotectant methods, compositions, and screening methods thereof |
EP1635823A1 (en) * | 2003-05-20 | 2006-03-22 | TransTech Pharma Inc. | Rage antagonists as agents to reverse amyloidosis and diseases associated therewith |
CN101468970B (zh) | 2008-04-25 | 2011-05-11 | 暨南大学 | 一种硝酮类化合物及其制备方法和在制药中的应用 |
EP2470510B1 (en) | 2009-09-30 | 2014-05-14 | TransTech Pharma, LLC | Substituted imidazole derivatives for treatment of alzheimers disease. |
JP5885620B2 (ja) * | 2012-08-22 | 2016-03-15 | 四国化成工業株式会社 | 2−(2−フリル)イミダゾール化合物及び酸化防止剤 |
FR3012460B1 (fr) | 2013-10-25 | 2015-12-11 | Michelin & Cie | Composition de caoutchouc comprenant un elastomere dienique portant des fonctions imidazole reparties de facon aleatoire le long de la chaine |
FR3012451B1 (fr) | 2013-10-25 | 2016-11-11 | Michelin & Cie | Compose 1,3-dipolaire portant une fonction imidazole |
FR3012458B1 (fr) * | 2013-10-25 | 2015-10-30 | Michelin & Cie | Composition de caoutchouc comprenant un additif compose 1,3-dipolaire portant une fonction imidazole |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0643403B2 (ja) * | 1986-01-25 | 1994-06-08 | 四国化成工業株式会社 | イミダゾール―アルドキシム化合物の合成方法 |
US4803282A (en) * | 1986-08-27 | 1989-02-07 | Pennwalt Corporation | Alpha-substituted ketonitrone derivatives |
ATE209908T1 (de) * | 1991-06-18 | 2001-12-15 | Oklahoma Med Res Found | RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN |
US5455272A (en) * | 1993-10-22 | 1995-10-03 | Oklahoma Medical Research Foundation | Spin trap nitronyl hindered phenols |
WO1997019054A1 (en) * | 1995-11-17 | 1997-05-29 | Florida International University | Azulenyl nitrone spin trapping agents, methods of making and using same |
-
1998
- 1998-06-26 FR FR9808116A patent/FR2780404B1/fr not_active Expired - Fee Related
-
1999
- 1999-06-04 CA CA002274621A patent/CA2274621C/fr not_active Expired - Fee Related
- 1999-06-22 JP JP11175839A patent/JP2000026428A/ja active Pending
- 1999-06-23 NO NO19993122A patent/NO312722B1/no not_active IP Right Cessation
- 1999-06-24 AT AT99401565T patent/ATE223904T1/de not_active IP Right Cessation
- 1999-06-24 DE DE69902851T patent/DE69902851T2/de not_active Expired - Fee Related
- 1999-06-24 EP EP99401565A patent/EP0967207B1/fr not_active Expired - Lifetime
- 1999-06-24 ES ES99401565T patent/ES2183492T3/es not_active Expired - Lifetime
- 1999-06-24 DK DK99401565T patent/DK0967207T3/da active
- 1999-06-24 PT PT99401565T patent/PT967207E/pt unknown
- 1999-06-25 US US09/340,088 patent/US6034250A/en not_active Expired - Fee Related
- 1999-06-25 ZA ZA9904201A patent/ZA994201B/xx unknown
- 1999-06-25 AU AU36800/99A patent/AU747203B2/en not_active Ceased
- 1999-06-25 CN CNB991112148A patent/CN1153766C/zh not_active Expired - Fee Related
- 1999-06-25 BR BR9903282-1A patent/BR9903282A/pt not_active IP Right Cessation
- 1999-06-25 NZ NZ336460A patent/NZ336460A/xx unknown
- 1999-06-25 HU HU9902199A patent/HUP9902199A1/hu not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0967207B1 (fr) | 2002-09-11 |
AU3680099A (en) | 2000-01-13 |
NZ336460A (en) | 2000-05-26 |
CN1153766C (zh) | 2004-06-16 |
US6034250A (en) | 2000-03-07 |
DE69902851T2 (de) | 2003-05-28 |
HUP9902199A1 (hu) | 2000-06-28 |
NO993122D0 (no) | 1999-06-23 |
CA2274621A1 (fr) | 1999-12-26 |
CA2274621C (fr) | 2004-01-20 |
BR9903282A (pt) | 2000-04-18 |
ZA994201B (en) | 2000-01-11 |
JP2000026428A (ja) | 2000-01-25 |
FR2780404B1 (fr) | 2001-04-13 |
CN1245169A (zh) | 2000-02-23 |
FR2780404A1 (fr) | 1999-12-31 |
AU747203B2 (en) | 2002-05-09 |
NO312722B1 (no) | 2002-06-24 |
EP0967207A1 (fr) | 1999-12-29 |
ES2183492T3 (es) | 2003-03-16 |
DK0967207T3 (da) | 2003-01-20 |
ATE223904T1 (de) | 2002-09-15 |
DE69902851D1 (de) | 2002-10-17 |
NO993122L (no) | 1999-12-27 |
HU9902199D0 (en) | 1999-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT967207E (pt) | Novos derivados de nitrona processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
MX9204746A (es) | Nuevos derivados de tiazolilbenzofuranos, procedimientos para la preparacion de los mismos y las composiciones farmaceuticas que los contienen. | |
PT94925A (pt) | Processo para a preparacao de derivados de tiazol e de composicoes farmaceuticas que os contem | |
ES2088933T3 (es) | Derivados de pirazol, procedimientos para su preparacion y composicion farmaceutica que los contiene. | |
AR058967A2 (es) | Derivados de triazolo[4,5-d] pirimidina composiciones farmaceuticas que los contienen y proceso de preparacion para dichos compuestos | |
MX9202142A (es) | Nuevos derivados de urea, proceso para su preparacion, y composicion farmaceutica que los comprende. | |
BR8400887A (pt) | Processo para a preparacao de derivados de guanidina,composicoes herbicidas,composicoes reguladoras do crescimento de plantas,aplicacoes dos ditos derivados,e processo para a preparacao de tais composicoes | |
NO912630L (no) | Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler som antiarteriosklerotiske midler | |
ES2176204T3 (es) | Antidepresivos que contienen un derivado de xantina. | |
AR042273A1 (es) | Derivados de pirazol, procedimiento para prepararlos y las composiciones farmaceuticas que los contienen | |
PT96916A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo um macrolido | |
ES549542A0 (es) | Un procedimiento para preparar nuevos derivados de benzo- triazol- y benzoxazolamina | |
BR9909739A (pt) | Benzotiadiazóis e derivados | |
IT1171880B (it) | Derivati di 2-ammino-3-acilammino-6-benzilammino-piridina aventi azione antiepilettica e procedimento per la loro produzione | |
BR9802804A (pt) | Compostos benzimidazol, benzoxazol e benzotiazol, processo para sua preparação e composições farmacéuticas contendo os mesmos. | |
BR1100991A (pt) | Compostos, processo para preparação dos mesmos, medicamentos, e, compostos intermediários | |
GB9718903D0 (en) | Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents | |
PT83725B (pt) | Processo para preparacao de novos derivados da 3-oxadiol-beta-carbolina e 3-carboxilato-beta-carbolina e de composicoes farmaceuticas que os contem | |
DE69323667D1 (de) | 4-substituierte 1,2,4-Triazolderivate | |
PT89643A (pt) | Processo para a preparacao de derivados de 2-{(4-piperidinil)-metil}-1,2,3,4-tetrahidro-isoquinoleina e de composicoes farmaceuticas que os contem | |
PT97991A (pt) | Processo para a preparacao de derivados de 2-(aminoalquil)-5-(arilalquil)-1,3-dioxanos e de composicoes farmaceuticas que os contem | |
BR9502079A (pt) | Composto,formulação farmaceutica e processo para preparar um composto | |
FI874789A0 (fi) | Menetelmä valmistaa farmakologisesti aktiivisia substituoituja 1H-imidatsoleja | |
DK0447116T3 (da) | Urinstof-derivater, deres fremstilling samt lægemidler indeholdende sådanne derivater | |
PT1257552E (pt) | Derivados de xantina, intermediarios e aplicacao ao tratamento de osteoporose |